About Index Trending news
Lists
Pricing
CytomX Therapeutics

CytomX Therapeutics

CytomX Therapeutics

CytomX Therapeutics is an early-stage biotechnology company developing Probodies, proteolytically-activated antibodies.

Elsewhere

Alexa global traffic share

06 Jan 2015
$20,000,000
Venture capital (Series C)
31 Jul 2012
$11,000,000
Venture capital (Series B)
03 Mar 2010
$2,500,000
Convertible Note